Parexel

Parexel International fell 84 cents, or 3.4%, to 23.65, after Goldman Sachs analysts cut their investment rating on the shares to "sell" from "neutral," citing valuation and the chance of greater margin pressures.

Blue Chips Take Europe Medicine Brendan Conway 2011

A Merck BioVentures unit will be formed within Parexel; financial terms of the deal weren't disclosed.

Merck Teams Up With Parexel on Biosimilars Peter Loftus 2011

He works at a division of Parexel International, a clinical research firm, and wants to add accounting skills to his degree in management.

Back to School Laura Saunders 2011

Quintiles and other big CROs, including Covance and Parexel, have benefited from the trend away from developing drugs for acute infectious diseases toward testing drugs that address chronic medical problems like Alzheimer's.

Money, Math And Medicine Matthew Herper 2010

Shares of Parexel, which runs clinical trials for drug makers and medical-device companies, did drop some at the time — then lost a lot more when the broader market collapsed in the fall.

Health-Care Providers 2009

Many drug companies have been trimming their research-and-development budgets, which could eat into growth for contract-research organizations such as Parexel.

Health-Care Providers 2009

Health-care stocks led much of the gain for the Russell yesterday, including jumps from Parexel, up $2.60, or 5.2%, to $53 and Gentiva Health, up 1.10, or 5.8%, to 19.93.

Parexel 2008

Parexel, based in Waltham, Mass., contracts with drug makers to test new medicines.

Even monkeys aren’t the same | The Blog of Michael R. Eades, M.D. 2006

Within an hour of receiving the milky white drug in a Parexel research ward in the hospital on March 13, the volunteers were racked with chills, pain and nausea, said Rob O., who asked that his last name not be used, for fear that he might be hurt professionally.

Even monkeys aren’t the same | The Blog of Michael R. Eades, M.D. 2006

(Voice-over): Guy Dickerson (ph) was unemployed two years ago when he signed up for a kidney drug trial, run by the same U.S. firm, Parexel.

CNN Transcript Mar 16, 2006 2006